Clinical profile, cardiac involvement and outcome of children admitted with multisystem inflammatory syndrome in PICU at GB Pant children hospital Srinagar
DOI:
https://doi.org/10.18203/2349-3291.ijcp20231489Keywords:
Cardiac abnormalities, COVID-19, Multisystem inflammatory syndrome, ShockAbstract
Background: Multisystem inflammatory syndrome in children (MIS-C) is a severe hyper inflammatory post infectious complication of acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, which typically occurs 2-6 weeks after exposure to SARS-CoV-2. Aim was to determine the clinical profile, cardiac involvement and outcome of children admitted with multisystem inflammatory syndrome in pediatric intensive care unit.
Methods: This prospective observational study was conducted in pediatric intensive care unit over period of two years. After informed consent from parents, all those patients meeting inclusion criteria were subjected to complete history, general and systemic physical examination. Routine baseline investigations included CBC, LFT, KFT, ABG, serum calcium and phosphorous, and other investigations like echocardiography, COVID-19 RAT and RTPCR and various inflammatory markers like serum ferritin, pro-calcitonin, CRP and ESR whenever required were done.
Results: In our study out of 77 MIS-C patients 40 were males and 37 were females with a male female ratio of 1.1:1. The mean average age was 7.4 years. Out of them 47 (61%) patients had a history of COVID-19 infection/contact with positive COVID-19 cases 3 to 4 weeks before presentation. In our study gastrointestinal, respiratory, and cardiac systems were mostly involved. Rash and conjunctival congestion was seen in 81% of MIS-C patients. On echocardiography out of 77 MIS-C patients, 15 (19.5%) had pericardial effusion, 25 (32.5%) had coronary artery dilatations and 32 patients (41.5%) had left ventricular systolic dysfunction with LVEF <55%.
Conclusions: Pediatric multisystem inflammatory syndrome is a serious and life-threatening illnesses having a significant impact on morbidity and mortality.
References
Feldstein LR, Tenforde MW, Friedman KG, Newhams M, Rose EB, Dapul H, et al. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. Jama. 2021;325(11):1074-87.
Angurana SK, Awasthi P, Thakur A, Randhawa MS, Nallasamy K, Kumar et al. Intensive care needs and short-term outcome of multisystem inflammatory syndrome in children (MIS-C): Experience from North India. J Trop Pediatr. 2021;67(3):fmab055.
World Health Organization. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19. 2020 May 15, 2020; Available from: https://www.who.int/news-room/commentaries/detail/multisyste inflammatory syndrome-in-children-and-adolescents-with-covid-19. Accessed on 1 December 2022.
Angurana SK, Kumar V, Nallasamy K, Kumar MR, Naganur S, Kumar M, et al. Clinico-laboratory profile, intensive care needs and short-term outcome of multisystem inflammatory syndrome in children (MISC): experience during first and second waves from north India. J Trop Pediatr. 2022;68(5):fmac068.
Nayak S, Panda PC, Biswal B, Agarwalla SK, Satapathy AK. Eastern India Collaboration on Multisystem Inflammatory Syndrome in Children (EICOMISC): a multicenter observational study of 134 cases. Front Pediatr. 2022;10:834039.
Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. Jama. 2020;324(3):259-69.
Davies P, Evans C, Kanthimathinathan HK, Lillie J, Brierley J, Waters G, et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc Health. 2020;4(9):669-77.
Lee PY, Day-Lewis M, Henderson LA, Friedman KG, Lo J, Roberts JE, et al. Distinct clinical and immunological features of SARS–CoV-2–induced multisystem inflammatory syndrome in children. J Clin Investig. 2020;130(11):5942-50.
Valverde I, Singh Y, Sanchez-de-Toledo J, Theocharis P, Chikermane A, Di Filippo S, et al. Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe. Circulation. 2021;143(1):21-32.
Jain S, Sen S, Lakshmivenkateshiah S, Bobhate P, Venkatesh S, Udani S, et al. Multisystem inflammatory syndrome in children with COVID-19 in Mumbai, India. Indian Pediatr. 2020;57:1015-9.
Feldstein LR, Rose EB, Horwitz SM. CDC COVID-19 Response Team. Multisystem inflammatory syndrome in US children and adolescents. N Engl J Med. 2020;383(4):334-46.
Godfred-Cato S, Bryant B, Leung J, Oster ME, Conklin L, Abrams J, et al. COVID-19–associated multisystem inflammatory syndrome in children- United States, March–July 2020. Morb Mortal Week Rep. 2020;69(32):1074.
Dhanalakshmi K, Venkataraman A, Balasubramanian S, Madhusudan M, Amperayani S, Putilibai S, et al. Epidemiological and clinical profile of pediatric inflammatory multisystem syndrome- temporally associated with SARS-CoV-2 (PIMS-TS) in Indian children. Indian Pediatr. 2020;57:1010-4.
Feldstein LR, Tenforde MW, Friedman KG, Newhams M, Rose EB, Dapul H, et al. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. Jama. 2021;325(11):1074-87.
Sen B, Sarkar M, Raychaudhuri D, Pal P, Roychowdhoury S, Chattopadhyay A, et al. Clinical profile and outcome of pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2 series in Eastern India. Med J DY Patil Vidyapeeth. 2022;5:S 210-4.
Lima-Setta F, Magalhães-Barbosa MC, Rodrigues-Santos G, Figueiredo EA, Jacques ML, Zeitel RS. Brazilian Research Network in Pediatric Intensive Care (BRnet-PIC). Multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 pandemic in Brazil: a multicenter, prospective cohort study. J Pediatr (Rio J). 2021;97(03):354-61.
Balagurunathan M, Natarajan T, Karthikeyan J, Palanisamy V. Clinical spectrum and short-term outcomes of multisystem inflammatory syndrome in children in a south Indian hospital 20212;63:531-7.
Bagri NK, Deepak RK, Meena S, Gupta SK, Prakash S, Setlur K, et al. Outcomes of multisystem inflammatory syndrome in children temporally related to COVID-19: a longitudinal study. Rheumatol Int. 2022;42(3):477-84.
